Oracle stock finished Nov. 18 at $113.89, around 65% below its September 2025 record.
Oracle expects revenue to rise 30% to 34% in its fiscal second quarter, which ends this month.
Management's guidance has adjusted earnings per share rising a slower 21% to 25%, excluding a one-time gain.
Oracle (NYSE:ORCL) stock finished Wednesday, Nov. 18, at $113.89, its lowest close since April 30, 2024. Shares are now around 65% below their record close of $328.33 in September 2025, and they're off about 42% so far in 2026.
That price is even under what Oracle's latest shareholders paid. On Nov. 2, the cloud giant priced 86.2 million new shares at $116 each. After underwriting fees, Oracle kept around $114.59 a share.
Missed AI’s "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our analysts, we’re only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »
Still, the business keeps speeding up. Oracle expects revenue to grow 30% to 34% year over year in its fiscal second quarter, which ends later this month.
But I think the profit side of that forecast matters more for the stock, and it doesn't look as strong.
Image source: The Motley Fool.
Showing how fast its cloud infrastructure business is ramping, Oracle's revenue climbed 30% year over year to $19.3 billion in the fiscal first quarter of 2027 (the three months ended Aug. 31, 2026). That was an acceleration from the 21% and 22% growth in the two quarters before it -- and from just 14% in the quarter before that. Cloud infrastructure revenue alone surged 121% to $7.4 billion.
Also, Oracle booked over $30 billion in new artificial intelligence (AI) cloud contracts during fiscal Q1. That raised its remaining performance obligations (contracted revenue it hasn't recognized yet) to $664 billion.
The fiscal Q2 guidance calls for that rate to hold or even pick up.
Earnings, however, aren't expected to keep up.
Over the past three reported quarters, Oracle's non-GAAP (adjusted) earnings per share climbed about as fast as revenue did. It rose 21% in fiscal Q3, 20% in fiscal Q4 (excluding one-time investment gains), and 30% in fiscal Q1.
The fiscal Q2 forecast breaks that pattern. Management sees earnings per share between $1.85 and $1.93 on an adjusted basis. When a one-time gain from selling Oracle's stake in chipmaker Ampere is taken out of the year-ago quarter, that's growth of 21% to 25%, or around 9 percentage points behind the revenue guide.
The gap probably comes from costs that show up before the revenue does. Oracle's depreciation more than doubled to $3.2 billion in fiscal Q1 as new data centers came online. Interest expense rose 55% as its borrowing grew. And the $20 billion of stock Oracle sold under an at-the-market program that quarter spreads its earnings across more shares.
Sure, Oracle's long-term plan already allows for some of this. At its Oct. 28 investor day, management targeted a non-GAAP operating margin of 40% or higher in fiscal 2030, a little under the 42% it hit in fiscal Q1. But it still calls for at least $21 a share in adjusted earnings that year. Getting there from the $8.10 Oracle sees this fiscal year would take earnings growth of around 37% a year.
Demand has to hold up, too. Bloomberg reported on Nov. 6 that Microsoft is phasing out a 2023 deal to rent AI computing capacity from Oracle, reportedly because the servers had older graphics chips. Oracle said demand for its AI infrastructure is still strong, older chips included.
True, one deal of undisclosed size is small next to a $664 billion backlog. But it shows that customers might quit paying for older hardware when better chips arrive.
At roughly $114, Oracle shares trade at about 14 times this fiscal year's expected earnings. That uses the $8.10 in adjusted earnings per share management is guiding for in the year ending May 31, 2027. For comparison, the S&P 500 is priced at about 18 times the earnings its companies are expected to make in the next 12 months. That's a discount to the average big company, though Oracle's $8.10 target is about 19% above fiscal 2026's adjusted earnings per share, excluding one-time gains.
When I covered Oracle's new funding cap in late October, the stock was around $145, or about 18 times the same expected earnings. I called that a fair price. Oracle reaffirmed its $8.10 target at its investor day, and the shares have since dropped about 21%.
Does that make Oracle stock worth buying now? I think it's worth a look, even with the heaviest spending still ahead. Management expects capital expenditures to peak this fiscal year and next, and it doesn't see positive free cash flow until the second half of fiscal 2028.
Fiscal Q2 still needs to show earnings growth in the 21%-to-25% range, and a miss might drive shares down. But at this price, I think the stock already allows profits to trail sales for a while.
Before you buy stock in Oracle, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Oracle wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $322,605!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $927,581!*
Now, it’s worth noting Stock Advisor’s total average return is 790% — a market-crushing outperformance compared to 202% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of November 20, 2026.
Daniel Sparks and his clients do not have positions in any of the stocks mentioned. The Motley Fool has positions in and recommends Microsoft and Oracle. The Motley Fool has a disclosure policy.